Company: ZCARW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110391
Chunk: 746

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 4
Chunk 746
---
 4.99% or 9.99% of the shares
of Common Stock outstanding. Also issued along with the shares of Common Stock and/or the Pre-Funded Warrants were (x) Series A Warrants
to initially purchase up to an aggregate of 8,680,443 shares of Common Stock, which does not reflect the Second Reverse Split, subject
to certain adjustments and (y) Series B Warrants to initially purchase no shares of Common Stock, subject to certain adjustments as provided
in the Series B Warrants. As a result of the First Closing, the Company received $4,786,963 of cash and cash equivalents after giving
effect to offering fees and expenses.

Further, on February 4, 2025,
the Company held the Second Closing of this Offering for gross proceeds of $1,437,936 (before deduction of fees to the Placement Agent
and other offering expenses payable by the Company). The Placement Agent in this Offering acted as exclusive placement agent at the Second
Closing. At the Second Closing, the Company issued an aggregate of (i) 1,049,796 shares of Common Stock, which does not reflect the Second
Reverse Split (ii) Pre-Funded Warrants issued to certain of the investors, at their option, exercisable for an aggregate of up to 872,000
shares of Common Stock, which does not reflect the Second Reverse Split, to the extent that the issuance of shares of Common Stock would
cause such Investors to beneficially own more than 4.99% or 9.99% of the shares of Common Stock outstanding. Also issued along with the
shares of Common Stock and/or the Pre-Funded Warrants were (x) Series A Warrants to initially purchase up to an aggregate of 4,804,491
shares of Common Stock, which does not reflect the Second Reverse Split, subject to certain adjustments and (y) Series B Warrants to initially
purchase no shares of Common Stock, subject to certain adjustments as provided in the Series B Warrants. As a result of the Second Closing,
the Company received $1,249,911 of cash and cash equivalents after giving effect to offering fees and expenses.

80

On March 31, 2025, the Company
further entered into a securities purchase agreement, substantially in the same form as the December 2024 SPA and the January 2025 SPA
with certain additional accredited investors in connection with the third closing of the Offering (the “Third Closing